Dover Advisors LLC Sells 1,083 Shares of MetLife, Inc. (NYSE:MET)

Dover Advisors LLC lowered its holdings in MetLife, Inc. (NYSE:METFree Report) by 19.2% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 4,560 shares of the financial services provider’s stock after selling 1,083 shares during the quarter. Dover Advisors LLC’s holdings in MetLife were worth $302,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds have also added to or reduced their stakes in the business. Silver Oak Securities Incorporated bought a new stake in MetLife in the fourth quarter valued at about $230,000. Convergence Investment Partners LLC grew its stake in MetLife by 3.4% during the fourth quarter. Convergence Investment Partners LLC now owns 16,774 shares of the financial services provider’s stock worth $1,109,000 after buying an additional 553 shares during the last quarter. Principle Wealth Partners LLC bought a new stake in MetLife during the fourth quarter worth about $207,000. Intact Investment Management Inc. grew its stake in MetLife by 25.7% during the fourth quarter. Intact Investment Management Inc. now owns 8,800 shares of the financial services provider’s stock worth $582,000 after buying an additional 1,800 shares during the last quarter. Finally, Russell Investments Group Ltd. grew its stake in MetLife by 7.7% during the fourth quarter. Russell Investments Group Ltd. now owns 848,196 shares of the financial services provider’s stock worth $56,101,000 after buying an additional 60,364 shares during the last quarter. Institutional investors own 89.81% of the company’s stock.

MetLife Stock Down 2.1 %

Shares of MET stock traded down $1.48 on Friday, hitting $70.42. 5,650,572 shares of the stock were exchanged, compared to its average volume of 2,506,510. The company has a current ratio of 0.16, a quick ratio of 0.16 and a debt-to-equity ratio of 0.53. The firm has a market capitalization of $50.92 billion, a P/E ratio of 38.48, a price-to-earnings-growth ratio of 0.53 and a beta of 1.04. The business has a 50-day moving average of $71.44 and a 200 day moving average of $67.22. MetLife, Inc. has a fifty-two week low of $48.95 and a fifty-two week high of $74.68.

MetLife (NYSE:METGet Free Report) last posted its quarterly earnings data on Wednesday, January 31st. The financial services provider reported $1.93 earnings per share for the quarter, missing the consensus estimate of $1.95 by ($0.02). The firm had revenue of $18.72 billion for the quarter, compared to analyst estimates of $18.07 billion. MetLife had a return on equity of 19.48% and a net margin of 2.36%. Equities analysts anticipate that MetLife, Inc. will post 8.71 EPS for the current year.

MetLife Increases Dividend

The business also recently announced a quarterly dividend, which will be paid on Tuesday, June 11th. Investors of record on Tuesday, May 7th will be issued a dividend of $0.545 per share. This represents a $2.18 annualized dividend and a yield of 3.10%. The ex-dividend date of this dividend is Monday, May 6th. This is a positive change from MetLife’s previous quarterly dividend of $0.52. MetLife’s dividend payout ratio is presently 113.66%.

Analyst Upgrades and Downgrades

Several analysts have weighed in on the stock. Piper Sandler upped their price objective on shares of MetLife from $74.00 to $85.00 and gave the stock an “overweight” rating in a research note on Friday, April 5th. UBS Group decreased their price target on shares of MetLife from $87.00 to $82.00 and set a “buy” rating on the stock in a research note on Monday, February 5th. Wells Fargo & Company increased their price target on shares of MetLife from $83.00 to $86.00 and gave the company an “overweight” rating in a research note on Thursday, April 11th. The Goldman Sachs Group raised shares of MetLife from a “neutral” rating to a “buy” rating and raised their price objective for the company from $70.00 to $80.00 in a research note on Monday, January 8th. Finally, Keefe, Bruyette & Woods raised their price target on MetLife from $82.00 to $87.00 and gave the stock an “outperform” rating in a research report on Wednesday, April 10th. Two research analysts have rated the stock with a hold rating and twelve have assigned a buy rating to the company. According to MarketBeat, MetLife currently has an average rating of “Moderate Buy” and a consensus price target of $79.23.

Get Our Latest Report on MET

Insider Buying and Selling

In related news, EVP Bill Pappas sold 27,000 shares of the company’s stock in a transaction dated Monday, March 18th. The stock was sold at an average price of $72.27, for a total transaction of $1,951,290.00. Following the sale, the executive vice president now owns 57,768 shares in the company, valued at $4,174,893.36. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. In other MetLife news, insider Ramy Tadros sold 4,026 shares of the company’s stock in a transaction that occurred on Wednesday, March 13th. The stock was sold at an average price of $71.90, for a total value of $289,469.40. Following the sale, the insider now owns 146,981 shares in the company, valued at $10,567,933.90. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Also, EVP Bill Pappas sold 27,000 shares of the company’s stock in a transaction that occurred on Monday, March 18th. The shares were sold at an average price of $72.27, for a total value of $1,951,290.00. Following the completion of the sale, the executive vice president now owns 57,768 shares in the company, valued at approximately $4,174,893.36. The disclosure for this sale can be found here. 0.32% of the stock is currently owned by corporate insiders.

MetLife Profile

(Free Report)

MetLife, Inc, a financial services company, provides insurance, annuities, employee benefits, and asset management services worldwide. It operates through six segments: Retirement and Income Solutions; Group Benefits; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short-and long-term disability, individual disability, pet insurance, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and general and separate account, and synthetic guaranteed interest contracts, as well as private floating rate funding agreements.

Featured Stories

Want to see what other hedge funds are holding MET? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for MetLife, Inc. (NYSE:METFree Report).

Institutional Ownership by Quarter for MetLife (NYSE:MET)

Receive News & Ratings for MetLife Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MetLife and related companies with MarketBeat.com's FREE daily email newsletter.